Association between PM2.5 exposure and risk of Parkinson’s disease in individuals with chronic obstructive pulmonary disease in Taiwan: a nested case-control study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: This cohort study investigated the correlation between Parkinson’s disease (PD) risk and chronic obstructive pulmonary disease (COPD) risk under particulate matter with an aerodynamic diameter ≤2.5 μm (PM2.5) exposure. METHODS: Data from the National Health Research Institutes of Taiwan were used in this study. The Environmental Protection Administration of Taiwan established an air quality monitoring network for monitoring Taiwan’s general air quality. COPD was indicated by at least 3 outpatient records and 1 hospitalization for COPD. After the implementation of age, sex, and endpoint matching at a 1:4 ratio, 137 patients and 548 patients were included in the case group and control group, respectively. Based on the 2005 World Health Organization (WHO) standards, monthly air particle concentration data were classified into the following 4 groups in analyses of exposure–response relationships: normal level, and 1.0, 1.5, and 2.0 times the WHO level ([concentration ≥2]×25 μg/m3×number of exposure months). RESULTS: A multivariate logistic regression revealed that the 1.0 and 1.5 WHO level groups did not significantly differ from the normal level group, but the 2.0 WHO level did (odds ratio, 4.091; 95% confidence interval, 1.180 to 14.188; p=0.038). CONCLUSIONS: Elevated PM2.5 concentrations were significantly correlated with an increased risk of PD among patients with COPD. Furthermore, exposure to high PM2.5 levels can further increase the risk of PD.
Abstract
OBJECTIVES: This cohort study investigated the correlation between Parkinson’s disease (PD) risk and chronic obstructive pulmonary disease (COPD) risk under particulate matter with an aerodynamic diameter ≤2.5 μm (PM2.5) exposure. METHODS: Data from the National Health Research Institutes of Taiwan were used in this study. The Environmental Protection Administration of Taiwan established an air quality monitoring network for monitoring Taiwan’s general air quality. COPD was indicated by at least 3 outpatient records and 1 hospitalization for COPD. After the implementation of age, sex, and endpoint matching at a 1:4 ratio, 137 patients and 548 patients were included in the case group and control group, respectively. Based on the 2005 World Health Organization (WHO) standards, monthly air particle concentration data were classified into the following 4 groups in analyses of exposure–response relationships: normal level, and 1.0, 1.5, and 2.0 times the WHO level ([concentration ≥2]×25 μg/m3×number of exposure months). RESULTS: A multivariate logistic regression revealed that the 1.0 and 1.5 WHO level groups did not significantly differ from the normal level group, but the 2.0 WHO level did (odds ratio, 4.091; 95% confidence interval, 1.180 to 14.188; p=0.038). CONCLUSIONS: Elevated PM2.5 concentrations were significantly correlated with an increased risk of PD among patients with COPD. Furthermore, exposure to high PM2.5 levels can further increase the risk of PD.
참고문헌 (36)
- Bloem BR, "Parkinson’s disease", Lancet, 397, pp.2284~2303 (2021)
- Opara J, "Motor assessment in Parkinson`s disease", Ann Agric Environ Med, 24, pp.411~415 (2017)
- Zhang Q, "Approach to cognitive impairment in Parkinson’s disease", Neurotherapeutics, 17, pp.1495~1510 (2020)
- Aarsland D, "Parkinson disease-associated cognitive impairment", Nat Rev Dis Primers, 7, pp.47~ (2021)
- Dorsey ER, "The Parkinson pandemic-a call to action", JAMA Neurol, 75, pp.9~10 (2018)
- Ng JS, "Palliative care for Parkinson’s disease", Ann Palliat Med, 7, pp.296~303 (2018)
- Christenson SA, "Chronic obstructive pulmonary disease", Lancet, 399, pp.2227~2242 (2022)
- Cheng SL, "Update on guidelines for the treatment of COPD in Taiwan using evidence and GRADE system-based recommendations", J Formos Med Assoc, 120, pp.1821~1844 (2021)
- Crisafulli E, "Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation", Thorax, 63, pp.487~492 (2008)
- Cavaillès A, "Comorbidities of COPD", Eur Respir Rev, 22, pp.454~475 (2013)
- Putcha N, "Comorbidities and chronic obstructive pulmonary disease : prevalence, influence on outcomes, and management", Semin Respir Crit Care Med, 36, pp.575~591 (2015)
- Li CH, "The association between chronic obstructive pulmonary disease and Parkinson’s disease : a nationwide population-based retrospective cohort study", QJM, 108, pp.39~45 (2015)
- Arbex MA, "Urban air pollution and chronic obstructive pulmonary disease-related emergency department visits", J Epidemiol Community Health, 63, pp.777~783 (2009)
- Zhu RX, "Relationship between particulate matter(PM2. 5)and hospitalizations and mortality of chronic obstructive pulmonary disease patients : a meta-analysis", Am J Med Sci, 359, pp.354~364 (2020)
- Shi L, "Long-term effects of PM2·5 on neurological disorders in the American Medicare population : a longitudinal cohort study", Lancet Planet Health, 4, pp.e557~e565 (2020)
- Wang Y, "Exposure to PM2. 5 aggravates Parkinson’s disease via inhibition of autophagy and mitophagy pathway", Toxicology, 456, pp.152770~ (2021)
- Wu TY, "An overview of the healthcare system in Taiwan", London J Prim Care(Abingdon), 3, pp.115~119 (2010)
- Sun HY, "Association between PM2. 5 exposure level and primary open-angle glaucoma in Taiwanese adults : a nested case-control study", Int J Environ Res Public Health, 18, pp.1714~ (2021)
- Gothe H, "Algorithms to identify COPD in health systems with and without access to ICD coding : a systematic review", BMC Health Serv Res, 19, pp.737~ (2019)
- Swarztrauber K, "Identifying and distinguishing cases of parkinsonism and Parkinson’s disease using ICD-9 CM codes and pharmacy data", Mov Disord, 20, pp.964~970 (2005)
- Lee YF, "Economic growth and income inequality : the modern Taiwan experience", J Contemp China, 17, pp.361~374 (2008)
- Lin YJ, "Urbanization and the utilization of outpatient services under National Health Insurance in Taiwan", Health Policy, 103, pp.236~243 (2011)
- Santiago JA, "Biological and clinical implications of comorbidities in Parkinson’s disease", Front Aging Neurosci, 9, pp.394~ (2017)
- Block ML, "The outdoor air pollution and brain health workshop", Neurotoxicology, 33, pp.972~984 (2012)
- Campbell A, "Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain", Neurotoxicology, 26, pp.133~140 (2005)
- Levesque S, "Air pollution & the brain : subchronic diesel exhaust exposure causes neuroinflammation and elevates early markers of neurodegenerative disease", J Neuroinflammation, 8, pp.105~ (2011)
- Levesque S, "Diesel exhaust activates and primes microglia : air pollution, neuroinflammation, and regulation of dopaminergic neurotoxicity", Environ Health Perspect, 119, pp.1149~1155 (2011)
- Angoa-Pérez M, "Estrogen counteracts ozone-induced oxidative stress and nigral neuronal death", Neuroreport, 17, pp.629~633 (2006)
- Santiago-López D, "Oxidative stress, progressive damage in the substantia nigra and plasma dopamine oxidation, in rats chronically exposed to ozone", Toxicol Lett, 197, pp.193~200 (2010)
- Kirrane EF, "Associations of ozone and PM2. 5 concentrations with Parkinson’s disease among participants in the agricultural health study", J Occup Environ Med, 57, pp.509~517 (2015)
- Wu TY, "An overview of the healthcare system in Taiwan", London J Prim Care(Abingdon), 3, pp.115~119 (2010)
- Lin YJ, "Urbanization and the utilization of outpatient services under National Health Insurance in Taiwan", Health Policy, 103(2-3), pp.236~243 (2011)
- Madhikarmi NL, "Antioxidant enzymes and oxidative stress in the erythrocytes of iron deficiency anemic patients supplemented with vitamins", Iran Biomed J, 18, pp.82~87 (2014)
- Bissinger R, "Oxidative stress, eryptosis and anemia : a pivotal mechanistic nexus in systemic diseases", FEBS J, 286, pp.826~854 (2019)
- Ghosh MC, "Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins", Neurobiol Dis, 81, pp.66~75 (2015)
- Marras C, "The complexities of hormonal influences and risk of Parkinson’s disease", Mov Disord, 29, pp.845~848 (2014)